Experience

Katie Kazem

    • MaxCyte – $202 Million IPO 


    • AvePoint to Combine With Apex Technology, a Special Purpose Acquisition Company, at $2 Billion Value 


    • Landos Biopharma – $100 Million IPO 


    • Nanobiotix – $113 Million IPO 


    • AppHarvest to Combine With Novus Capital, a Special Purpose Acquisition Company 


    • RenalytixAI – $85 Million IPO 


    • Innate Pharma - $79 Million IPO 


    • Genfit - $155 Million IPO 


    • Entasis Therapeutics – $75 Million IPO 


    • Autolus – $173 Million IPO